Synthetic peptide conjugated to KLH, from the C-terminal region of Human SKA3.
Our Abpromise guarantee covers the use of ab118560 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 0.5 - 1 µg/ml. Predicted molecular weight: 46 kDa.|
|ELISA||Use at an assay dependent concentration.|
|IHC-P||Use a concentration of 5 µg/ml.|
ab118560 has not yet been referenced specifically in any publications.